Login to Your Account



NewCo News: Start-up Cyterix Crosses the Pond, Raises $9.2M Series A

By Jennifer Boggs


Friday, June 24, 2011
The challenge in treating cancer has been delivering cell-killing agents to tumors while sparing normal tissue, and Cyterix Pharmaceuticals Inc., an April 2010 start-up, is moving toward the clinic with a new targeted approach by taking advantage of extra-hepatic cytochrome P450.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription